New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 8, 2014
17:10 EDTCERSCerus files $250M mixed securities shelf
News For CERS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2015
08:12 EDTCERSCerus' Intercept supplier Ash Stevens receives FDA facility approval
Ash Stevens, a provider of global contract pharmaceutical drug substance development and Active Pharmaceutical Ingredient manufacturing services, received approval from the FDA for its manufacturing facility in Riverview, Michigan for the manufacture of Amotosalen, the API in Cerus' INTERCEPT Blood System. The INTERCEPT Blood System recently received FDA approval for ex vivo preparation of pathogen-reduced plasma and platelet components in order to reduce the risk of transfusion-transmitted infection.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use